Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

IGFBP-7 serum levels correlate with clinical severity in patients with heart failure

Dec. 30, 2013

Novartis presents additional clinical data for serelaxin

Dec. 30, 2013

Chinese herbal medicine demonstrates safety and efficacy in first U.S. trial in liver fibrosis

Dec. 30, 2013

Researchers from Fusion Pharma present a novel pan-BCR/ABL inhibitor, PF-114

Dec. 30, 2013

Data reported from first trial of Thalagen gene therapy for beta-thalassemia

Dec. 30, 2013

Arrowhead Research presents first-in-human results for ARC-520

Dec. 27, 2013

Sotatercept well tolerated in patients with beta-thalassemia

Dec. 27, 2013

Cancer vaccine K562/GM-CSF evaluated in patients with myelodysplastic syndrome

Dec. 27, 2013

MAPK 14 inhibitor devised for use as a CNS probe

Dec. 24, 2013

Pleiotropic pathway modulator CC-122 evaluated in first-in-human trial

Dec. 24, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...